Health24.com | No apparent harm or benefit from hydroxychloroquine – study

A study performed in New York hospitals found no evidence of either harm or benefit from giving the malaria drug hydroxychloroquine to severely ill coronavirus patients.

“The risk of intubation or death was not significantly higher or lower among patients who received hydroxychloroquine than among those who did not,” the authors of the study said.

They said the study, published on Thursday in The New England Journal of Medicine, “should not be taken to rule out either benefit or harm of hydroxychloroquine treatment.”

“However, our findings do not support the use of hydroxychloroquine at present, outside randomised clinical trials testing its efficacy,” they said.

US President Donald Trump has frequently touted the use of hydroxychloroquine as a treatment for coronavirus patients.

No significant association

Hydroxychloroquine and a related compound chloroquine have been used for decades to treat malaria, as well as the autoimmune disorders lupus and rheumatoid arthritis.

The observational study was conducted among emergency room patients at the New York-Presbyterian Hospital and Columbia University Irving Medical Center and funded by the National Institutes of Health.

For the study, 811 patients received two doses of 600mg of hydroxychloroquine on the first day and 400 mg daily for four days.

Another 565 patients did not receive the drug.

Comparing the two groups, “there was no significant association between hydroxychloroquine use and intubation or death,” the study said.

Health Canada, the European Medicines Agency and the US Food and Drug Administration have warned against the use of hydroxychloroquine to treat Covid-19 outside of clinical trial

US regulators last week authorized the emergency use of the experimental drug remdesivir against Covid-19 after it was shown in a major clinical trial to shorten the time to recovery in some coronavirus patients.

READ | Coronavirus | The chloroquine debate: Two experts weigh in

READ | Covid-19: The problems caused by the chloroquine and hydroxychloroquine hype

READ | More evidence that Trump-touted drugs won’t curb Covid-19

Image credit: Getty Images

Share Button

Newly discovered cell type plays crucial role in immune response to respiratory infections

With a discovery that could rewrite the immunology textbooks, an international group of scientists, including the teams of Bart Lambrecht, Martin Guilliams, Hamida Hammad, and Charlotte Scott (all from the VIB-UGent Center for Inflammation Research) identified a new type of antigen-presenting immune cell. These cells, that are part of an expanding family of dendritic cells, play a crucial role presenting antigens to other immune cells during respiratory virus infections, and could explain how convalescent plasma helps to boost immune responses in virus-infected patients.

Inflammation and immunity

When our body faces an infection, it responds with inflammation and fever. This is a sign that the immune system does its work, and leads to the activation of many cells, like soldiers in an army. Dendritic cells (DCs) are the generals of that army. They can precisely activate and instruct the soldiers to kill infected cells by presenting antigens derived from the ‘invaders’ to cells of the immune system.

Mistaken identity

There are several types of DCs that perform antigen-presenting functions in the body. A first type of conventional DCs continuously scan the body for dangerous invaders, even when there is no infection. When there is inflammation triggered by infection, another subset of DCs emerges from inflammatory monocytes. Because monocyte-derived DCs are easily prepared in vitro from monocytes isolated form human blood, it was always assumed these cells were very important antigen-presenting cells. Clinical trials using monocyte-derived DCs in cancer therapy have however been disappointing.

A study by the teams of Bart Lambrecht, Martin Guilliams, Hamida Hammad, and Charlotte Scott (all from the VIB-UGent Center for Inflammation Research) and international colleagues, shows that monocyte-derived DCs are poor antigen-presenting cells, but have wrongly been assumed to have these functions because of a case of mistaken identity.

The scientists studied mice with a viral respiratory infection (pneumonia virus of mice and influenza virus) with single-cell technologies. This single-cell resolution allowed them to finely separate the monocyte-derived cells from other DCs during their response to the infection. They found that monocyte-derived DCs do exist, but actually do not present antigens. The reason for all the confusion in the past is that a look-alike new DC emerges — called inflammatory type 2 conventional DC, or inf-cDC2 — that combines some of the best characteristics of monocytes, macrophages, and conventional DCs, to induce the best form of immunity.

Bart Lambrecht: “This was a big surprise for us. We’ve all been taught that monocyte-derived cells are excellent antigen presenting cells, certainly when there’s inflammation. Now, we show that it’s actually a new hybrid DC type that’s doing all the work. This really changes what we know about the immune system and is very important knowledge for understanding respiratory viral infections and other inflammatory diseases.”

Martin Guilliams: “It took a massive team effort but the strength of single-cell sequencing has finally cracked the complex DC code. Many contradicting findings from the last two decades now make much more sense. This also opens tremendous therapeutic opportunities, since vaccination strategies can now be designed to trigger formation of inf-cDC2s and thus generate a stronger antiviral immune response.”

Charlotte Scott: “Through the use of single cell technologies we have been able to align all the findings from the past few years and identify the distinct cell types involved. Moving forward it will be very interesting to see under what other inflammatory conditions these inf-cDC2s are generated and how they can potentially be targeted therapeutically.”

Convalescent plasma and COVID-19

The findings of the researchers also have a direct relevance for the current COVID-19 pandemic, caused by another respiratory virus. An emergency treatment that is currently being explored is the use of convalescent plasma, or the blood plasma of recovered patients.

Cedric Bosteels, lead author of the new paper: “One of the unique features of the new DCs is that they express functional Fc receptors for antibodies that are found in the plasma of patients who have recovered from COVID-19”

This study is the first to show that one of the mechanisms through which convalescent plasma and the virus-specific antibodies in it work, is via boosting of inf-cDC2. Since boosted DCs induce a much stronger immune response, this study reveals a new target for therapeutic intervention for viral infections and other inflammatory diseases.

Funding

This study was funded by the European Research Council, University Ghent, Research Foundation Flanders (FWO), and the Health Research Council New Zealand.

Share Button

Flies sleep when need arises to adapt to new situations

Flies that cannot take to the air respond by sleeping more as they learn to adapt to their flightlessness, according to a study from Washington University School of Medicine in St. Louis. The findings, published May 8 in Science Advances, suggest that sleep may be an evolutionary tool that helps animals adapt to challenging new situations.

“We know that sleep is involved in creativity and insight,” said senior author Paul Shaw, PhD, a professor of neuroscience. “Have you ever slept on a problem, and when you wake up you’ve found the answer? Anxiety keeps people up at night, but if you find yourself in a dangerous environment, or in a situation that you don’t know how to deal with, sleep may be exactly what you need to respond to it effectively.”

Fruit flies’ sleep looks a lot like people’s. Baby flies need a lot of sleep, but as they get older, their need for sleep diminishes. Flies become more alert with caffeine and drowsier with antihistamines. And if you keep a fly awake one day, it will sleep more the next.

These similarities suggest that the sleep habits of flies might shed light on the sleep habits of people. To explore the relationship between challenging circumstances and sleep, Shaw and staff scientist and first author Krishna Melnattur, PhD, took away flies’ ability to fly.

Baby flies must expand their wings in the first half hour or so after emerging from pupal cases, or their wings will not develop properly. The researchers placed some newly emerged flies in tiny containers so they could not expand their wings, and they genetically modified other flies so that the insects’ wings failed to expand. Both scenarios rendered the young flies permanently flightless. The researchers also grounded older flies by disabling their wings. In all cases, faced with the inability to fly, the animals slept more than usual.

In subsequent experiments, the researchers traced the neurological circuit that signals to the brain that the wings aren’t functioning and triggers the impulse to sleep more.

“When we identified the neurons that were activated when we cut or glued the wings of adult flies, they turned out to be the same neurons involved in the normal developmental process of wing expansion after emergence,” Melnattur said.

The fact that wing injury and normal wing development are linked to sleep through the same neurological circuitry makes sense from an evolutionary standpoint, the researchers said. The circuit is active in young flies because their developing brains need sleep as the animals expand their wings, learn to fly and begin to navigate the world around them.

“And then the whole circuit can get reactivated later in life when something happens that forces a fly to adapt to a new normal,” Shaw said. “Suddenly, its brain needs to be as flexible as when it was young. It can no longer fly, but it still needs to get food, it needs to compete for mates, it needs to avoid dying. We think that sleep amplifies the brain plasticity the fly needs to survive.”

Shaw and Melnattur are planning experiments to determine whether increased sleep helps flightless flies survive. Their findings also may provide clues to why some people sleep more than others and why some sleep disorders arise.

“There’s huge variation in sleep time among people,” Shaw said. “Some people need five hours a night; some need nine. Sleep is an ancient process, and we’ve evolved mechanisms to change our sleep-wake balance to help us meet our needs. If these mechanisms get inappropriately activated, say by a traumatic event that triggers post-traumatic stress disorder, it can create a situation in which you’re sleeping too much or too little and it’s no longer matching up with your needs, and then you have a sleep disorder.”

Story Source:

Materials provided by Washington University School of Medicine. Original written by Tamara Bhandari. Note: Content may be edited for style and length.

Share Button

Inspired by cheetahs, researchers build fastest soft robots yet

Inspired by the biomechanics of cheetahs, researchers have developed a new type of soft robot that is capable of moving more quickly on solid surfaces or in the water than previous generations of soft robots. The new soft robotics are also capable of grabbing objects delicately — or with sufficient strength to lift heavy objects.

“Cheetahs are the fastest creatures on land, and they derive their speed and power from the flexing of their spines,” says Jie Yin, an assistant professor of mechanical and aerospace engineering at North Carolina State University and corresponding author of a paper on the new soft robots.

“We were inspired by the cheetah to create a type of soft robot that has a spring-powered, ‘bistable’ spine, meaning that the robot has two stable states,” Yin says. “We can switch between these stable states rapidly by pumping air into channels that line the soft, silicone robot. Switching between the two states releases a significant amount of energy, allowing the robot to quickly exert force against the ground. This enables the robot to gallop across the surface, meaning that its feet leave the ground.

“Previous soft robots were crawlers, remaining in contact with the ground at all times. This limits their speed.”

The fastest soft robots until now could move at speeds of up to 0.8 body lengths per second on flat, solid surfaces. The new class of soft robots, which are called “Leveraging Elastic instabilities for Amplified Performance” (LEAP), are able to reach speeds of up to 2.7 body lengths per second — more than three times faster — at a low actuation frequency of about 3Hz. These new robots are also capable of running up steep inclines, which can be challenging or impossible for soft robots that exert less force against the ground.

These “galloping” LEAP robots are approximately 7 centimeters long and weigh about 45 grams.

The researchers also demonstrated that the LEAP design could improve swimming speeds for soft robots. Attaching a fin, rather than feet, a LEAP robot was able to swim at a speed of 0.78 body lengths per second, as compared to 0.7 body lengths per second for the previous fastest swimming soft robot.

“We also demonstrated the use of several soft robots working together, like pincers, to grab objects,” Yin says. “By tuning the force exerted by the robots, we were able to lift objects as delicate as an egg, as well as objects weighing 10 kilograms or more.”

The researchers note that this work serves as a proof of concept, and are optimistic that they can modify the design to make LEAP robots that are even faster and more powerful.

“Potential applications include search and rescue technologies, where speed is essential, and industrial manufacturing robotics,” Yin says. “For example, imagine production line robotics that are faster, but still capable of handling fragile objects.

“We’re open to collaborating with the private sector to fine-tune ways they can incorporate this technology into their operations.”

The work was done with support from the National Science Foundation under grants 2010717 and 2005374.

Story Source:

Materials provided by North Carolina State University. Note: Content may be edited for style and length.

Share Button

Plasma medicine research highlights antibacterial effects and potential uses

As interest in the application of plasma medicine — the use of low-temperature plasma (LTP) created by an electrical discharge to address medical problems — continues to grow, so does the need for research advancements proving its capabilities and potential impacts on the health care industry. Across the world, many research groups are investigating plasma medicine for applications including cancer treatment and the accelerated healing of chronic wounds, among others.

Researchers from Penn State’s College of Engineering, College of Agricultural Sciences and College of Medicine say direct LTP treatment and plasma-activated media are effective treatments against bacteria found in liquid cultures. The researchers also say they have devised a unique way to create plasma directly in liquids.

The team, comprised of engineers, physicists, veterinary and biomedical scientists and medical professionals, is using an atmospheric-pressure plasma jet to use room temperature — “cold” — plasma to treat bacteria.

Plasma, the fourth state of matter, is typically very hot — thousands to millions of degrees. By using plasma generated at atmospheric pressure or in liquids, the researchers can create molecules and atoms with antibacterial effects without burning anything. Sean Knecht, assistant teaching professor of engineering design at Penn State and leader of the Cross-disciplinary Laboratory for Integrated Plasma Science and Engineering, said this process creates many different types of reactive particles, making the likelihood of bacterial mutations to simultaneously combat all the particles almost nonexistent.

Knecht explained that the team’s research results, published in Scientific Reports, show that plasma technology generates large amounts of reactive oxygen species or reactive particles created from molecules that contain oxygen atoms, including oxygen molecules in the air and water vapor. The plasma’s effect on different bacteria such as E. coli and Staph. aureus is significant, resulting in many bacterial deaths through multiple generations.

“Over the course of four generations of bacteria, these bacteria do not acquire any form of resistance to the plasma treatment,” he said.

Girish Kirimanjeswara, associate professor of veterinary and biomedical sciences at Penn State, said this is extremely important due to the typical way bacteria mutate, making them resistant to antibiotics.

Antibiotics target a specific metabolic pathway, essential protein or nucleic acids in bacteria. Because of this, antibiotics have to enter a bacterial cell to find and bind to that specific target. Any bacterial mutation that decreases an antibiotic’s entry capabilities or increases its rate of exit makes the antibiotic less effective. Mutations happen naturally at a low rate but can rapidly accumulate by selection pressure when introduced to antibiotics aimed at fighting the bacteria.

According to Kirimanjeswara, the team’s research results show that plasma treatment produces various reactive oxygen species at a concentration high enough to kill bacteria, but low enough to not have negative impacts on human cells. He explained that the oxygen species quickly target virtually every part of the bacteria including proteins, lipids and nucleic acids.

“One can call it a sledgehammer approach,” Kirimanjeswara said. “It is difficult to develop resistance by any single mutation or even by a bunch of mutations.”

The team also applied these findings to design a system that can create plasma directly in liquids. The researchers intend to create plasma in blood to address cardiovascular infections directly at the source. To do so, high electric voltage and large electric currents are typically used. In the plasma system created by the researchers, the electrical current and energy that might reach the patient are minimized by using dielectric, or electrically-insulating, materials. Materials that the team would typically use to create the plasma include glass and ceramic due to their capability to withstand high local temperatures. These materials tend to make blood clot and may not be very flexible, a necessity if they are to be used in the cardiovascular system. The team is investigating insulating coatings that are biocompatible, or acceptable by the human body, and flexible. Knecht said the team has identified a polymer called Parylene-C and reported the initial results in the journal IEEE Transactions on Radiation and Plasma Medical Sciences. The team is further pursuing this avenue, as polymers have low melting points and may not withstand repeated exposure to plasma.

“Biocompatible polymers can be used for plasma generation in biological liquids, but their lifetime is limited,” Knecht said. “New unique plasma generation designs must be developed to produce lower intensity plasma discharges that can extend their lifetime. That is what we are continuing to work on.”

Kirimanjeswara said scientists typically work to understand how different bacteria cause disease or how host immune responses eliminate bacteria to create new antibiotics and vaccines. Though these more traditional approaches are essential, they are often gradual and time-consuming. The team’s innovative research highlights the importance of continuing to investigate new ways to combat bacteria.

“Transformative and cross-disciplinary approaches have the potential to speed up finding solutions to urgent global problems,” he said. “It is important for the general public to be aware of and appreciate the fact that the scientific community is engaged in several approaches, some traditional and others nontraditional, to combat the growing problem of antibiotic resistance. We hope our research reinforces the idea of embracing nonantibiotic approaches to treat bacterial infections in the future.”

Story Source:

Materials provided by Penn State. Original written by Samantha Chavanic. Note: Content may be edited for style and length.

Share Button

Promising study offers hope for Menkes disease patients

A Texas A&M AgriLife research team has good news for patients with copper-deficiency disorders, especially young children diagnosed with Menkes disease.

A team led by James Sacchettini, Ph.D. professor and Welch Chair of Science, and Vishal Gohil, Ph.D., associate professor, both from the Department of Biochemistry and Biophysics at Texas A&M University, published a paper in Science outlining their latest discoveries of how using the cancer drug elesclomol holds promise for treating copper deficiencies in Menkes disease.

The research funding was provided by the Chancellor’s Research Initiative of The Texas A&M University System, the Welch Foundation and the National Institutes of Health.

“With all biology connected, it’s great to see this innovative research from the agriculture and life sciences departments making a significant connection to an area of human health,” said Patrick J. Stover, Ph.D., vice chancellor of Texas A&M AgriLife, dean of the College of Agriculture and Life Sciences and director of AgriLife Research.

Menkes disease

Menkes is a rare genetic disorder occurring in about 1 in every 50,000-300,000 births. Young children with the disorder typically die within three years of life due to a genetic mutation that limits their body’s ability to absorb and utilize copper from their diet. The copper deficiency leads to severe brain damage and neuromuscular deficits.

“Experimental treatments have not been effective at overcoming the most severe symptoms of the disease or early mortality,” Sacchettini said.

“Our current work documenting the efficacy of elesclomol in a mouse model of Menkes disease takes us one step closer to the clinical trials,” Gohil said.

Copper deficiency

Normally, copper is acquired through diet from foods such as fish, organ meats, nuts and beans, said Liam Guthrie, a doctoral candidate in Sacchettini’s lab and lead author of the paper. He explained that dietary copper is normally absorbed in the intestines, then exported to the liver for distribution throughout the body.

In Menkes disease, that process is disrupted. The copper absorbed by intestinal cells must be exported into the blood by a copper transport protein. If that protein is not functioning well, due to genetic mutations, the copper can’t be distributed to various parts of the body. The brain, heart and other tissues thus become copper deficient.

And, when copper is deficient in these tissues, certain enzymes fail to activate, Gohil explained. One such enzyme is mitochondrial cytochrome oxidase complex, which is required for energy production.

“Mitochondrial cytochrome oxidase is an enzyme present in almost all cells in our body and uses a majority of the oxygen that we breathe,” Gohil said.

This enzyme only works if it has copper in it, he explained. Without copper, the enzyme won’t function, and the body stops working due to lack of energy production.

Finding the drug

Gohil began working on this project in 2012, and in 2014 his team began focusing on elesclomol and showed that it can deliver copper to mitochondria and restore the production of cytochrome oxidase protein complex in copper-deficient yeast and human cells, as well as in zebrafish.

In 2017, Gohil’s graduate student Shivatheja Soma and postdoctoral fellow Mohammad Zulkifli, Ph.D., began collaborating with Guthrie, Andres Silva and others from the Sacchettini group. They began to translate the laboratory results into a preclinical mouse model of Menkes disease.

The team focused on developing procedures for using elesclomol to treat Menkes and optimizing treatment strategies to find the right doses.

“These were difficult and time-consuming experiments that required special precautions because we were working with very sick mice, ones that carried the same type of mutation as humans with severe Menkes disease,” Guthrie said. “These mice showed very similar symptoms to babies with the disease. We had hope that if we could successfully treat these mice, we would be able to translate the discoveries to infants.”

Sacchettini said the first step was to overcome the side effects of using a cancer drug to treat the disease. The major breakthrough came when their group came up with a new way to prepare the drug.

“We found that by mixing elesclomol with copper in a special formulation, we could keep the new form of the drug soluble prior to administration,” he said. “With this approach we were able to dramatically increase survival of the mice and, importantly, to normalize their brain development.”

The collaborators from the University of Maryland, led by Byung-Eun Kim, Ph.D., showed that elesclomol could overcome more than just defects in the transporter that causes Menkes disease. The medication also targeted a second copper transporter, one implicated in the development of hypertrophic heart and liver disorders in mice and humans — indicating the therapeutic applications of elesclomol may not be limited to Menkes disease.

Gohil’s group and Michael Petris, Ph.D., from the University of Missouri, showed that elesclomol escorted copper to different tissues and delivered it to copper-utilizing enzymes like cytochrome c oxidase in mitochondria.

Promising results

Through this mechanism, elesclomol prevented brain damage and improved the survival of Menkes mice from a mere 14 days to over 200 days.

While there is still more work to do in preparation for treating infants with Menkes disease, Sacchettini and Gohil say they are confident they will soon be able to extend the survival and quality of life for those born with this devastating disease.

Share Button

To err is human, to learn, divine

The human brain is a highly advanced information processor composed of more than 86 billion neurons. Humans are adept at recognizing patterns from complex networks, such as languages, without any formal instruction. Previously, cognitive scientists tried to explain this ability by depicting the brain as a highly optimized computer, but there is now discussion among neuroscientists that this model might not accurately reflect how the brain works.

Now, Penn researchers have developed an different model for how the brain interprets patterns from complex networks. Published in Nature Communications, this new model shows that the ability to detect patterns stems in part from the brain’s goal to represent things in the simplest way possible. Their model depicts the brain as constantly balancing accuracy with simplicity when making decisions. The work was conducted by physics Ph.D. student Christopher Lynn, neuroscience Ph.D. student Ari Kahn, and professor Danielle Bassett.

This new model is built upon the idea that people make mistakes while trying to make sense of patterns, and these errors are essential to get a glimpse of the bigger picture. “If you look at a pointillist painting up close, you can correctly identify every dot. If you step back 20 feet, the details get fuzzy, but you’ll gain a better sense of the overall structure,” says Lynn.

To test their hypothesis, the researchers ran a set of experiments similar to a previous study by Kahn. That study found that when participants were shown repeating elements in a sequence, such as A-B-C-B, etc., they were automatically sensitive to certain patterns without being explicitly aware that the patterns existed. “If you experience a sequence of information, such as listening to speech, you can pick up on certain statistics between elements without being aware of what those statistics are,” says Kahn.

To understand how the brain automatically understands such complex associations within sequences, 360 study participants were shown a computer screen with five gray squares corresponding to five keys on a keyboard. As two of the five squares changed from gray to red, the participants had to strike the computer keys that corresponded to the changing squares. For the participants, the pattern of color-changing squares was random, but the sequences were actually generated using two kinds of networks.

The researchers found that the structure of the network impacted how quickly the participants could respond to the stimuli, an indication of their expectations of the underlying patterns. Responses were quicker when participants were shown sequences that were generated using a modular network compared to sequences coming from a lattice network.

While these two types of networks look different to the human eye at a large scale, they are actually statistically identical to one another at small scales. There are the same number of connections between the nodes and edges, even though the overall shape is different. “A computer would not care about this difference in large-scale structure, but it’s being picked up by the brain. Subjects could better understand the modular network’s underlying structure and anticipate the upcoming image,” says Lynn.

Using tools from information theory and reinforcement learning, the researchers were able to use this data to implement a metric of complexity called entropy. “Being very random is the least complex thing you could do, whereas if you were learning the sequence very precisely, that’s the most complex thing you can do. The balance between errors and complexity, or negative entropy, gives rise to the predictions that the model gives,” says Lynn.

Their resulting model of how the brain processes information depicts the brain as balancing two opposing pressures: complexity versus accuracy. “You can be very complex and learn well, but then you are working really hard to learn patterns,” says Lynn. “Or, you have a lower complexity process, which is easier, but you are not going to learn the patterns as well.”

With their new model, the researchers were also able to quantify this balance using a parameter beta. If beta is zero, the brain makes a lot of errors but minimizes complexity. If beta is high, then the brain is taking precautions to avoid making errors. “All beta does is tune between which is dominating,” says Lynn. In this study, 20% of the participants had a small beta, 10% had high beta values, and the remaining 70% were somewhere in between. “You do see this wide spread of beta values across people,” he says.

Kahn says that this idea of balancing forces wasn’t surprising, given the huge amount of information the brain has to process under a limited amount of resources and without spending too much time on simple decisions. “The brain is already using up a huge amount of metabolic costs, so you really want to maximize what you are getting out,” he says. “If you think about something as basic as attention, there is an inherent trade off in maximizing accuracy versus everything else you are ignoring.”

And what about the role of making mistakes? Their model provides support for the idea that the human brain isn’t an optimal learning machine but rather that making mistakes, and learning from them, plays a huge role in behavior and cognition. It seems that being able to look at complex systems more broadly, like stepping away from a pointillist painting, gives the brain a better idea of overall relationships.

“Understanding structure, or how these elements relate to one another, can emerge from an imperfect encoding of the information. If someone were perfectly able to encode all of the incoming information, they wouldn’t necessarily understand the same kind of grouping of experiences that they do if there’s a little bit of fuzziness to it,” says Kahn.

“The coolest thing is that errors in how people are learning and perceiving the world are influencing our ability to learn structures. So we are very much divorced from how a computer would act,” says Lynn.

The researchers are now interested in what makes the modular network easier for the brain to interpret and are also conducting functional MRI studies to understand where in the brain these network associations are being formed. They are also curious as to whether people’s balance of complexity and accuracy is fluid, whether people can change on their own or if they are “set,” and also hope to do experiments using language inputs sometime in the future.

“After better understanding how healthy adult humans build these network models of our world, we are excited to turn to the study of psychiatric conditions like schizophrenia in which patients build inaccurate or otherwise altered models of their worlds,” says Bassett. “Our initial work paves the way for new efforts in the emerging field of computational psychiatry.”

This research was primarily supported by the U.S. Army Research Office through Grant DCIST- W911NF-17-2-0181 and National Science Foundation through Grant NSF PHY-1554488.

Share Button

Health24.com | Cellphones are ‘Trojan Horses’ for viruses, study finds

Cellphones carry all kinds of germs, a new study finds, and researchers say phones should be cleaned regularly to cut the risk for coronavirus transmission.

The advice follows a review of 56 studies that looked at the risk of cellphones being contaminated with bacteria, fungi or viruses. The investigations were conducted across 24 countries between 2006 and 2019, prior to the advent of Covid-19.

The review shows “that mobile phones not only carry bacteria but also viruses, fungi, and protozoa in the thousands”, said study author Lotti Tajouri, an associate professor of genomics and molecular biology at Bond University in Queensland, Australia.

On average, the review found that 68% of the mobile phones had been contaminated with a wide range of microorganisms. And some of those contaminants showed resistance to standard antibiotics.

Particularly receptive hosts

The investigators did not conduct any new tests to search for the presence of the Covid-19 virus on phones. However, Tajouri said his team “hypothesise strongly that mobile phones are responsible for the rapid propagation of COVID-19”.

Why? First of all, “the virus responsible for Covid-19 can live on glass, plastic, stainless steel for days,” Tajouri noted. And cellphones, he added, are “particularly receptive hosts for germs simply because we first never wash them, and we take them everywhere and all the time with us.”

That includes where people eat, where they sleep, and where they go to the bathroom, he observed, as well as onboard the planes and trains people use to travel the globe.

And while acknowledging that all everyday objects are contaminated in some way, Tajouri warned that “mobile phones are like international ambulatory five-star luxury hotels” for germs. In fact, he said, “no other type of everyday object can compete”.

That point was seconded by Dr Stephen Berger, co-founder of Global Infectious Diseases and Epidemiology Network (GIDEON) in Tel Aviv, Israel.

“Cellular phones are ideal vehicles for the virus of Covid-19,” he agreed. “They are repeatedly exposed to material exhaled from our mouth and nose, and spend literally hours in our rather filthy hands. Viruses of this type are known to survive on plastics and stainless steel for two to three hours; on aluminium for two to eight hours; on cardboard and paper for up to 24 hours; and on ceramic or glass for up to five days.”

Phones like our ‘third hand’

But Tajouri and Berger part ways when it comes to what we should do about it.

Tajouri’s advice: “Before you wash your hand, wash your phone,” he recommended.

“To be safe, every single one of us needs to first acknowledge that mobile phone is a source of microbial contamination,” he said, and to effectively treat phones like “our third hand”.

“You could do that by using a soft microfibre cloth with 70% ethanol or use of a non-abrasive disinfectant wipe to wipe off your phone,” said Tajouri, though he cautions users to consult phone manufacturers to identify cleaning products that are safe for electronic devices.

By contrast, Berger – who was not involved in the review – suggests keeping your eyes on the real culprit: your hands.

As a practical matter, he said, cellphones are shared about as often as a drinking straw. “And if the phone has been exposed only to your own hands and your own mouth, the potential for viral transmission vanishes,” Berger noted.

No need for compulsive cleaning

So, while he “would certainly avoid using the cellphone of a casual acquaintance, even while wearing a mask”, Berger said repetitive phone cleaning is unwarranted.

“Bottom line, there is no need to compulsively clean cellphones, or [for that matter] doorknobs, home railings, paper money, eyeglasses, hats, shoes, credit cards, or wristwatches,” Berger said. “Whenever these and other objects in our daily life are examined in the laboratory, a veritable ‘zoo’ of bacteria, parasites, fungi and viruses is discovered. But the common denominator for all of these is the human hand that touches them, and then goes to our mouth or nose.”

So it’s your hands, said Berger, rather than the phone itself, that “should certainly be thoroughly cleaned. As often as possible.”

The review was published online recently in the journal Travel Medicine and Infectious Disease.

READ | Do your keys, phone, money need disinfecting when you return home?

READ | Scientists tested WHO-recommended disinfectants against the coronavirus – and they are effective

READ | Can you catch the new coronavirus from your clothes?

Image credit: Rob Hampson, Unsplash

Share Button

Health24.com | Why lighting up and Covid-19 don’t mix

As evidence continues to grow that people who smoke are at greater risk of dying from Covid-19, health professionals are turning to a familiar message with new urgency: There may be no better time to quit than today.

While researchers gather more data as the virus spreads, both the World Health Organization and the Centers for Disease Control and Prevention have identified smoking as a risk factor for severe coronavirus-related disease and death.

Studies from Wuhan, China, where the coronavirus emerged in December, showed smokers were 1.4 times more likely to display severe Covid-19 symptoms and 2.4 times more likely to be sent to an intensive care unit, require mechanical ventilation or die, compared to non-smokers.

“This is such a new world, of course, but there’s no question that smoking makes your situation worse if you catch the virus,” said Dr Irving Kron, senior associate vice president for health sciences at the University of Arizona in Tucson. “If you get it, there is some evidence that smoking will change the propensity of your lungs to get infected. And as you know, if you get your lungs infected with this disease, that’s a bad plan.”

Preexisting heart disease

That’s when people can die, he said. Yet the biological changes brought about by smoking can cause more lung infections in everyday life, pandemic or no.

Studies are less conclusive about the potential dangers of Covid-19 for people who vape, Kron said. But vaping has been linked to asthma, chronic lung disease and cardiovascular disease.

That damage also opens the door for the coronavirus to become more dangerous.

“We know that a lot of people with coronavirus die of preexisting heart disease. So if you smoked, we know that affects your coronary arteries,” Kron said. “For sure, smoking – in terms of its long-term effects – increases your risk of mortality from coronavirus.”

People who share smoking devices, such as vape pens or hookah pipes, are especially at risk of spreading the virus, Rezk-Hanna said.

“Because smokers tend to share hookahs using the same mouthpiece, hookah smoking could increase the transmission of Covid-19 further,” she said. “We also know that because of the lack of regulation, hookah home delivery companies and hookah lounges may not properly clean their pipes, and because the coronavirus can survive on surfaces such as plastic or metal for up to several days, the risk of transmission is high.”

Immediate short-term health benefits

Similarly, the WHO suggested smokers who quit now would reduce their risk of infection simply because they will reduce the number of times they touch their mouths with their fingers.

While health officials are not able to predict a timeline in which the spread of the coronavirus will be under control, they point to data showing there are immediate short-term health benefits after a person gives up smoking.

“Smokers who quit begin to see better heart and lung health almost immediately,” Rezk-Hanna said. “Within minutes, the heart rate drops to normal levels. Within hours, carbon monoxide and other tobacco-related toxicant levels decline, and as a result, blood oxygen levels go up and coughing and wheezing start to improve.”

A study published in January in the journal Nature found that quitting smoking now may not only prevent future lung damage, it could cause healthy cells to begin repairing previous damage.

“There are just so many bad things about smoking, including the fact that it’s a nasty habit,” Kron said. “If you had your doubts before, now’s a great time to quit.”

AHA News for HealthDay

READ | Smokers, vapers in special danger from coronavirus

READ | Why the cigarette ban during lockdown? Five medical experts weigh in

READ | Coronavirus infection likely worse for vapers and smokers

Image credit: Franck V. on Unsplash

Share Button

Health24.com | Covid-19: What should public transport look like?

A few dozen people wearing homemade and medical masks sit waiting for taxis as drivers spray hand sanitiser on commuters and tell them where inside of the ubiquitous South African Toyota Quantum minibus taxis they may sit to keep the appropriate distance. 

The scene on this Friday morning is eerily quiet for Bosman taxi rank, usually one of Pretoria’s busiest and loudest spots. “The mood is very somber”, says Macdonald Makata, public relations officer of the South African National Taxi Council (SANTACO) in Tshwane.

Only about a fifth of the rank is operating, with vehicles filled to a maximum of 70%, sanitised regularly, and deep cleaned twice a week. All commuters are meant to wear masks, although only about half do, says Charles, who has been a taxi driver for about five years.

“It’s very difficult that(sic) but we have to follow,” he says of the regulations. Makata agrees that while the health measures are important, they are not easy to implement, since some commuters do not take them seriously and it is having a great financial impact on the industry. “In a way it is helping to flatten the curve,” he says, “but pocket-wise it is not helpful at all.”

Similar health and safety regulations are in place across the board in the different modes of private and public transport that is allowed during South Africa’s level four lockdown, with some buses and the Gautrain slowly resuming operations. 

Transport ministry spokesperson Ayanda Allie Paine says that they are testing the state of readiness and the viability of instituting the health measures at scale before reopening the Metrorail system during level three or two.

While the ministry is exploring a variety of future scenarios, Paine says the economy and budgets will have to be considered, “so one is fearful of saying that this is what we’ll do and for how long and whether or not it will be sustainable”.

The risk 

Despite the practical implementation being challenging, the need for health measures in public transport is undeniable. Professor Taryn Young is the head of the Department of Global Health and the director of the Centre for Evidence-based Health Care at Stellenbosch University, where she and a team recently conducted a rapid review of research linking public transport and respiratory viral infections like influenza. 

She says in simple terms “the risk of transmission within public transport comes from the fact that it is large numbers of people that will be very close to each other”. The studies confirmed that using public transport significantly increased your chances of influenza.

This risk is based on factors such as the proximity of commuters, the time spent traveling, and the inadequate ventilation in these spaces. Young notes that this may especially relate to people who are infected but not yet tested or showing symptoms.

She says another risk factor is that public transport, particularly over longer distances, can bring viral infections into new areas. 

The common interventions to mitigate this risk fall into four broad categories, namely environmental controls, respiratory etiquette, hand hygiene, and mask usage.

Young reminds that “it’s about a combination of strategies, it’s not just about doing one of these”. Encouragingly, these areas are already been addressed or planned for in South Africa. 

Environmental controls

Since SARS-CoV-2 spreads through airborne droplets that may be inhaled or touched, surface sanitisation is a key environmental aspect to control in public transport.

Hand sanitisers and deep cleaning seem to already be widely in place and Gauteng MEC for Public Transport, Jacob Mamabolo, is launching a provincial taxi disinfection programme aimed at increasing compliance with regulations. 

Sanitisation or health screening booths, like the ones recently installed by the Gautrain, are another option that is being considered by the ministry for larger-scale rollout. Paine says these may be used more widely because “they not only check your temperature, but they also spray with sanitisers that stay on your clothes and body for an hour while you’re commuting”.

Paine says they are also considering cashless systems in taxis as a way of increasing hygiene. “We are not there yet, but these discussions have already begun.” 

Responding to Spotlight about larger changes in the system, Transport Minister Fikile Mbalula says that “yes, structural innovation must be the new thing”.

He emphasises that the chosen changes must be value for money and says that he is also looking to changes made in other countries such as Turkey.

Mbalula uses the example of the sanitisation booths as something that can be implemented in larger transport spaces such as the rail network. “It is innovative, it is highly convenient, it is proper. That is what we want to see,” Mbalula says.

Fresh air

The other important and perhaps underrated environmental control mechanism is adequate ventilation. Young says the studies they reviewed showed that influenza risk dropped when air was filtered or improving ventilation in trains. 

Freelance biomedical engineer Munyaradzi Matose has researched how airborne tuberculosis is affected by ventilation in taxis in South Africa.

He found that opening the two front windows in an average minibus met the World Health Organization’s minimum recommendations for ventilation rates in general wards and outpatient departments.

He says this “reduces the risk by removing all the particulates in the air – almost 95% of that – within an hour”. This is a cost-effective and easy way to drastically reduce the risk of infection from airborne disease. 

In his research Matose monitored taxis driving to higher tuberculosis risk areas such as Gugulethu and Khayelitsha, and while drivers may open windows to call out to potential passengers, “consistent open windows throughout the journey didn’t happen much”.

He acknowledges that while it may decrease the health risk, wide-open windows are often impractical because of the noise levels, possible safety risk and discomfort at higher speeds. 

Matose advises that air conditioners may bring in a little fresh air, but this may not be enough, and may not be a feasible and affordable solution for drivers.

When told of Matose’s research as a possible solution, Makata at the Pretoria taxi rank laughs and says “in summer, yes you can afford to open windows, but in winter you can’t, how dare you”.

An additional precaution to clean the air regardless of the windows would be an adaptation of ultraviolet germicidal irradiation lamps and similar devices. These can be used directly on surfaces, as long as there is no human contact, but Matose says hospitals use an air filtering version in fan cabinets.

“In conjunction with ventilation it would be the ideal solution,” he says, and this would be a risk reduction measure when windows cannot be opened. The lamps can run continuously for about two years, but safety concerns would have to be evaluated.  

“There is potential for it to work, it’s just the willingness of either the taxi associations or the car manufacturers themselves to jump on board for disinfecting the air for their passengers.”

Matose has tried to convince manufacturers to invest in this before to no avail but says that in the time of COVID-19, the willingness may be higher. He says that longer term this may even allow for slightly fuller public transport, since “it opens up a whole new solution for people to feel safe in these packed environments”. 

Normalising etiquette

The other three categories of interventions that Young mentions are more up to the commuters than the transport system. Respiratory etiquette and hand hygiene practices, such as coughing into your elbow and avoiding touching surfaces and your face, can be encouraged but not entirely imposed.

Social distancing is being pushed by indicators on the floors of train stations and public spaces, but not always adhered to. Using fabric masks, while mandated by lockdown restrictions, can only be enforced to an extent, and even though homemade masks are often for sale at places such as Bosman rank, only a portion of commuters comply. 

Young says this comes down to engagement with all levels of the public transport community, including commuters. “For them to know what the risks are, for them to know how one can reduce this, and for them to come up with strategies for how this can be implemented.”

Makata echoes this when he speaks of the initial adjustment to the new regulations. “We felt very vulnerable, and it was all because there was very little information,” he says.

The drivers and owners were unsure about how the virus spreads and could not always explain the importance of the health measures to their clients. When discussing the research, such as Matose’s ventilation insights with Makata, he says these are the kinds of things they could implement if they understood the importance. “We lack that information, we are clueless.”

Continued or strengthened Covid-19 education specifically in the transport sector could address this. Makata suggests that having regular presence of health officials at ranks could help. 

National spokesperson of SANTACO, Thabisho Molelekwa, confirms that they are considering “setting up mobile clinics in bigger taxi ranks” along with other innovations such as “having automated sanitising devices inside taxis, digital messaging facilities with integrated sanitising systems”.

Structural changes 

While these health interventions are critical in reducing infection rates, the root of the risk is still linked. Young says it is linked to a system that puts many different people in close proximity over longer periods of time and distances. That cannot be reversed, but perhaps there are structural interventions that could help.

The most obvious approach so far has been to bring down the carrying capacity of transport, with taxis at 70% and the Gautrain at 50%, but this isn’t financially sustainable or likely able to provide the capacity needed once more people can return to work. 

Young says that “it starts with minimising the use of public transport” but since this isn’t easily feasible in the South African context, a particular focus for this should be on those with symptoms of a sickness. 

Competence Area Manager of Transport Systems and Operations at the Council for Scientific and Industrial Research (CSIR), Dr Mathetha Mokonyama, reminds that “although we refer to public transport as mass transport service, it is actually individuals who are travelling and not groups”.

Therefore, understanding the particular patterns and circumstances of commuters may make the system safer and more resilient, perhaps by making the system more efficient and catered to particular needs.  

Mokonyama says the mobility-as-a-service concept may be useful here. This combines the ideas of smart mobility and integrated transport to allow commuters to use Apps to get to their destinations in streamlined ways, often paid digitally. He says it “seeks to seamlessly match individual travel needs to services, and to also offer services in ways that respond to travel needs”.

This heightened level of efficiency and personalisation might have health benefits, because it may reduce travel time and the variability in the amount of people a commuter comes into contact with. 

Paine also says that system changes where variability – and therefore potentially the infection risk – is reduced are possible and feasible. She says that integrated public transport is of high importance to the ministry and implementation has started, and may even be expedited by the pandemic. “So, we are already starting to see the different modes of transport speaking to each other.”

Mokonyama does however concede that “given the volumes and complexity of travel patterns we have to invest in computational capabilities,” to implement mobility-as-a-service and that as a country “we have some way to go with information security capabilities and assurances that individual information will not be used for malicious purposes”. 

He says that other practical interventions could work to shift transport habits, such as price incentives for off-peak travel. “Working together with employers and schools to stagger working hours and school hours in order to reduce peak travel, will also reduce exposure risks.” 

“All these (changes, come at a cost, meaning the way transport is financed needs to be reconsidered,” Mokonyama says.

“This is very difficult,” says Professor Stephan Krygsman from the Department of Logistics at Stellenbosch University about the feasibility of these ideas. “Remember that transport, and public transport, is the lifeblood of cities and that it cannot be stopped or reinvented easily, because work commutes are often at set times and need for transportation at abnormal times, such as late-night hospital trips, is unpredictable,” he says.

While he recognises the greater problems in the system, Krygsman says for now the best may be to “keep the system running – just implement these safety measures”.

However, Krygsman says, the problems in the transport sector that ultimately lead to higher disease risk have a larger cause and therefore need more macro solutions.

“The irony is that the answer does not lie in transport, it lies in how we design our cities.” Krygsman explains that legacy spatial planning has created divides in cities, which makes traveling to and from outlying, often poorer neighborhoods, more expensive for those who live there. This affects the system, because “to lower the cost of travel, the transport is of very poor quality”. 

Taking a long term view, he says better designed lower-income neighbourhoods could create less reliance on public transport, possibly enhance system quality, and therefore make the country “more resilient to these types of shocks”.

Commuting in a Covid-19 world 

Researchers and officials can test and implement strategies that not only bring down health risks but might improve the system overall, including making it less crowded, more streamlined and possibly even addressing some of the financial challenges. 

But the public transport system in South Africa is a very large, multi-faceted beast. Adapting to the longer-term risk of COVID-19 will require complex solutions, political will, and careful negotiations. 

In the meantime, for the drivers spraying hand sanitiser at Bosman, and ranks like it around the country, changes are possible, but difficult. 

Charles says that even though some commuters have trouble complying “we as people, if we can follow the rules, we can win this”.

This article was produced by Spotlight – health journalism in the public interest. Sign upfor our newsletter.
Image credit: Elna Schütz, Spotlight

Share Button